Vertex Pharmaceuticals (VRTX) EBIT (QoQ) (2009 - 2026)
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) EBIT (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.56% |
| Mar 31, 2026 | -5.62% |
| Dec 31, 2025 | 1.66% |
| Sep 30, 2025 | 3.05% |
| Jun 30, 2025 | 82.69% |
| Mar 31, 2025 | -38.59% |
| Dec 31, 2024 | -8.09% |
| Sep 30, 2024 | 131.76% |
| Jun 30, 2024 | -408.44% |
| Mar 31, 2024 | 15.28% |
| Dec 31, 2023 | -4.78% |
| Sep 30, 2023 | 1.14% |
| Jun 30, 2023 | 31.76% |
| Mar 31, 2023 | -24.63% |
| Dec 31, 2022 | -8.27% |
| Sep 30, 2022 | 1.84% |
| Jun 30, 2022 | 6.28% |
| Mar 31, 2022 | 18.59% |
| Dec 31, 2021 | -16.77% |
| Sep 30, 2021 | 2,882.32% |